Enhanced biocompatibility of GPC by silver ion implantation

Simple item page
dc.contributor.authorZimmerman R.
dc.contributor.authorGürhan I.
dc.contributor.authorMuntele C.
dc.contributor.authorIla D.
dc.contributor.authorÖzdal-Kurt F.
dc.contributor.authorSen B.H.
dc.date.accessioned2024-07-22T08:23:34Z
dc.date.available2024-07-22T08:23:34Z
dc.date.issued2005
dc.description.abstractBiocompatible Glassy Polymeric Carbon (GPC) is used for artificial heart valves and in other biomedical applications. Although it is ideally suited for implants in the blood stream, tissue that normally forms around the moving parts of a GPC heart valve sometimes loses adhesion and creates embolisms downstream. Here we compare silver ion implantation and silver deposition, each of which strongly inhibits cell attachment on GPC. Inhibition of cell adhesion is a desirable improvement to current GPC cardiac implants. In vitro biocompatibility tests have been carried out with model cell lines to demonstrate that traces of silver can favorably influence the surface of GPC for biomedical applications. © 2006 Materials Research Society.
dc.identifier.issn02729172
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19577
dc.language.isoEnglish
dc.subjectBiocompatibility
dc.subjectBiomedical engineering
dc.subjectBlood
dc.subjectCell adhesion
dc.subjectGlass
dc.subjectHeart valve prostheses
dc.subjectIon implantation
dc.subjectSilver
dc.subjectBiomedical applications.
dc.subjectGlassy Polymeric Carbon (GPC)
dc.subjectHeart valves
dc.subjectImplants (surgical)
dc.titleEnhanced biocompatibility of GPC by silver ion implantation
dc.typeConference paper

Files

Collections

Scopus Koleksiyonu